REMSleep 510K Submission
REMSleep Holdings, Inc. (OTC PINK: RMSL) has announced that its submission K212087 has passed the acceptance review. The submission was found to contain all necessary elements for a substantive review, and a lead reviewer has been assigned to the case. The company plans to provide further updates as they become available.
This announcement follows the regulatory protocol and demonstrates the company's progress in its submission process, which may have implications for future developments.
- Submission K212087 has passed the acceptance review, indicating quality and completeness.
- A lead reviewer has been assigned, moving the process forward.
- None.
Acceptance Review Notification – Accepted
Tampa, FL, July 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL) is pleased to announce an acceptance review was conducted on REMSleep submission K212087, and it was found to contain all of the necessary elements and information needed to proceed with the substantive review. A lead reviewer has been assigned to REMSleep's submission. The company will release updates when available.
Forward-looking statements.
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. No information in this press release should be construed as any indication whatsoever of the Company's future revenues, results of operations or stock price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tom Wood
twood@remsleep.com
FAQ
What is the significance of REMSleep's submission K212087?
When was the acceptance review for RMSL conducted?
What are the next steps after the acceptance review for RMSL?
How does the acceptance review impact RMSL's stock performance?
